24 May 2013
Keywords: diovan, versus, norvasc, trial, novartis, pharma, conducting
Article | 09 October 1997
- Novartis Pharma is conducting a trial to compare the long-termeffects of its angiotensin II antagonist Diovan (valsartan) against those of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.